Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. [electronic resource]

By: Contributor(s): Producer: 20120326Description: 64-71 p. digitalISSN:
  • 1879-1379
Subject(s): Online resources: In: Journal of psychiatric research vol. 46
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.